ARTICLE | Company News
FDA extends Scotia's Foscan review
June 6, 2000 7:00 AM UTC
The agency will extend its review of the photodynamic therapy to treat cancer to October from July. Scotia (LSE:SOH) submitted additional data on Foscan at the FDA's request, which was made in April. ...